MaxLinear downgraded to Neutral at Susquehanna on end market headwinds

As previously reported, Susquehanna downgraded MaxLinear to Neutral from Positive with a price target of $15, down from $26. The firm notes a “number of high-profile pending lawsuits” that create uncertainty around future cash payments and customer relationships and also sees headwinds for “several key MaxLinear end markets,” the analyst tells investors.